Bahri operates cargo flights to transport medical equipment and supplies to KSA
July 2, 2020

RIYADH — In continuation of its ongoing efforts to support the Ministry of Health’s initiatives to contain and combat COVID-19 and as part of its SAR10 million worth of services donated to the Ministry, Bahri, a global leader in logistics and transportation, has been operating cargo flights from China to Saudi Arabia to transport medical equipment and supplies to the government of Saudi Arabia.

The special air cargo transportation comes as"...

Pandemic closes stores at Saudi Arabia’s biggest retail franchise group
July 2, 2020

LONDON: Saudi Arabia’s biggest retail franchise group reported a full year loss of SR577.5 million ($153.9 million) as the global shopping industry emerges from near paralysis.

Fawaz A. Alhokair & Co (Alhokair) is behind some of the region’s biggest brands and like other retail groups worldwide has been heavily exposed to the fallout from coronavirus-related lockdowns throughout"...

Cambridge opens 60-bed medical facility in Saudi Arabia
July 1, 2020

Cambridge Medical & Rehabilitation, a leading post-acute rehabilitation and long-term care facility in the UAE, has announced the opening of its first medical and rehabilitation facility in Saudi Arabia's Eastern Province.

The all-new 60-bed facility, CMRC Saudi Arabia is located between Dhahran and"...

Teijin Receives Marketing Approval for Merz’s Xeomin® Botulinum Toxin Type A in Japan
June 29, 2020

Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly announced today that Teijin Pharma has been granted approval by Japan’s Ministry of Health, Labor and Welfare (MHLW) to market Xeomin® (incobotulinumtoxinA) for intramuscular injection in 50, 100 or 200 units for the treatment of upper limb spasticity.

Daily Consumption of Walnuts Has a Positive Role in Improving Metabolic Syndrome
June 16, 2020

A new study suggests that consuming walnuts may help restore metabolic syndrome to a normal level or improve metabolic syndrome risk factors.

According to a paper published in Nutrition Research and Practice, a journal of the Korean Nutrition Society, regular consumption of walnuts may bring positive changes to metabolic syndrome status by increasing HDL cholesterol and decreasing fasting"...

Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030
March 12, 2020

Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/ As one of PSMF’s longest-standing board members, serving since 2013, Dr. Ramsay has been an advocate for patient......

Saudi surgical conference concludes in Riyadh
March 12, 2020

RIYADH: The 13th edition of the Saudi General Surgery Society Conference — organized by the Saudi General Surgery Society (SSGS) — concluded in Riyadh, the Saudi Press Agency reported on Wednesday.

The three-day conference was attended by doctors and consultants from a number of different countries and examined the latest surgical research and scientific papers, as well as providing"...

Heart failure remains a major cause of death and disability
March 12, 2020

RIYADH — Despite significant advances, heart failure remains a major cause of death and disability worldwide. Unfortunately, the problem is growing and accordingly the cost of chronic care and hospitalization are escalating.

Novel approaches are needed to reduce the burden of heart failure as well as to improve the quality of life of these patients.

Today more than ever, heart failure has to become a political and health care system"...

Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance
March 12, 2020

Regulatory News:

Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded its raised guidance for full-year 2019 on both net sales and EBITDA.

FINANCIAL PERFORMANCE: STRONG"...

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial
March 11, 2020

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients. The addition of ixazomib to lenalidomide and dexamethasone resulted in an improvement in median progression-free survival (PFS) of 13.5 months (35.3 months versus 21.8 months; hazard ratio [HR] 0.83; p=0.073); however, it did not meet the threshold for statistical significance. The safety profile associated with NINLARO from the TOURMALINE-MM2 trial was generally consistent with the existing prescribing information. Results from the TOURMALINE-MM2 study will be submitted to an upcoming medical congress.......